Group One Trading
ARRY

Group One Trading’s Array Biopharma Inc ARRY Stock Holding History

Group One Trading’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-351,100
Closed -$16.3M – 5872
2019
Q2 		$16.3M Buy
351,100
+327,300
+1,375% +$9.19M 0.15% 128
2019
Q1 		$580K Buy
23,800
+13,700
+136% +$285K 0.01% 1829
2018
Q4 		$144K Sell
10,100
-7,000
-41% -$106K ﹤0.01% 2930
2018
Q3 		$260K Sell
17,100
-200,400
-92% -$3.07M ﹤0.01% 2822
2018
Q2 		$3.65M Buy
217,500
+191,400
+733% +$3.04M 0.03% 717
2018
Q1 		$426K Sell
26,100
-72,700
-74% -$1.16M ﹤0.01% 2185
2017
Q4 		$1.26M Sell
98,800
-213,900
-68% -$2.43M 0.01% 1533
2017
Q3 		$3.85M Buy
312,700
+18,500
+6% +$172K 0.03% 636
2017
Q2 		$2.46M Sell
294,200
-308,000
-51% -$2.52M 0.03% 830
2017
Q1 		$5.38M Buy
602,200
+409,100
+212% +$4.35M 0.06% 378
2016
Q4 		$1.7M Sell
193,100
-87,700
-31% -$645K 0.02% 1008
2016
Q3 		$1.9M Buy
280,800
+152,900
+120% +$591K 0.02% 879
2016
Q2 		$455K Sell
127,900
-23,900
-16% -$77.9K 0.01% 1802
2016
Q1 		$448K Sell
151,800
-341,700
-69% -$1.02M 0.01% 1761
2015
Q4 		$2.08M Buy
493,500
+183,800
+59% +$839K 0.02% 827
2015
Q3 		$1.41M Sell
309,700
-333,700
-52% -$1.98M 0.02% 1014
2015
Q2 		$4.64M Buy
643,400
+200,000
+45% +$1.48M 0.06% 358
2015
Q1 		$3.27M Buy
443,400
+360,100
+432% +$2.56M 0.05% 412
2014
Q4 		$394K Sell
83,300
-353,900
-81% -$1.4M 0.01% 1740
2014
Q3 		$1.56M Sell
437,200
-161,700
-27% -$637K 0.02% 835
2014
Q2 		$2.73M Buy
598,900
+13,500
+2% +$55.8K 0.04% 539
2014
Q1 		$2.75M Buy
585,400
+184,000
+46% +$925K 0.05% 479
2013
Q4 		$2.01M Buy
401,400
+359,300
+853% +$1.96M 0.03% 651
2013
Q3 		$262K Buy
42,100
+4,300
+11% +$25.5K 0.01% 2145
2013
Q2 		$172K Buy
+37,800
New +$203K ﹤0.01% 2318

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Group One Trading's ARRY Position: Q3 2017 in Review

Group One Trading sold out of Array Biopharma Inc (ARRY) in Q3 2017, closing a stake of 172,370 shares — an estimated $1.6M sold.

Group One Trading first reported a position in ARRY in Q2 2013 and held it in 11 quarters. The position peaked at $2.19M in Q1 2017. 184 funds tracked by Wall St. Rank hold ARRY as of Q3 2017.

  • Group One Trading reported no remaining Array Biopharma Inc position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 172,370 Array Biopharma Inc shares in Q3 2017, an estimated $1.6M.
  • Group One Trading first reported a position in Array Biopharma Inc in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Array Biopharma Inc position peaked at $2.19M in Q1 2017.
  • 184 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.